Get started
Author

Hiroaki Soyama

Observed names: H Soyama, HIROAKI SOYAMA, Soyama, H.
ORCID: 0000-0003-0841-7743
Observed ORCID: 0000-0003-0841-7743
OpenAlex ID: A5048847387
Pretreatment Neutrophil-to-Lymphocyte Ratio Was a Predictor of Lymph Node Metastasis in Endometrial Cancer Patients
2019 · Tadashi Aoyama, Masashi Takano, et al. · Oncology · 65
JAK2/STAT3 pathway as a therapeutic target in ovarian cancers
2018 · Tomoyuki Yoshikawa, Morikazu Miyamoto, et al. · Oncology Letters · 52
PDF
Effect of routine rapid insertion of Bakri balloon tamponade on reducing hemorrhage from placenta previa during and after cesarean section
2017 · Hiroaki Soyama, Morikazu Miyamoto, et al. · Archives of Gynecology and Obstetrics · 44
Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers
2017 · Tomoyuki Yoshikawa, Masashi Takano, et al. · Cancer Chemotherapy and Pharmacology · 42
Analysis of prophylactic Bakri balloon tamponade failure in patients with placenta previa
2019 · Hiroaki Soyama, Morikazu Miyamoto, et al. · Taiwanese Journal of Obstetrics and Gynecology · 26
PDF
Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas
2017 · Morikazu Miyamoto, Masashi Takano, et al. · Journal of Gynecologic Oncology · 22
PDF
Phenoxodiol Increases Cisplatin Sensitivity in Ovarian Clear Cancer Cells Through XIAP Down-regulation and Autophagy Inhibition
2018 · MORIKAZU MIYAMOTO, MASASHI TAKANO, et al. · Anticancer Research · 20
PDF
Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy?
2017 · Tadashi Aoyama, Masashi Takano, et al. · Cancer Chemotherapy and Pharmacology · 19
Thrombotic events induce the worse prognosis in ovarian carcinomas and frequently develop in ovarian clear cell carcinoma
2019 · Kazuki Takasaki, Morikazu Miyamoto, et al. · International Journal of Clinical Oncology · 18
Cervical varicosities may predict placenta accreta in posterior placenta previa: a magnetic resonance imaging study
2017 · Hiroki Ishibashi, Morikazu Miyamoto, et al. · Archives of Gynecology and Obstetrics · 18
Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors
2020 · TAIRA HADA, MORIKAZU MIYAMOTO, et al. · In Vivo · 16
PDF
Marginal sinus placenta previa is a different entity in placenta previa: A retrospective study using magnetic resonance imaging
2018 · Hiroki Ishibashi, Morikazu Miyamoto, et al. · Taiwanese Journal of Obstetrics and Gynecology · 16
PDF
Factors favouring long-term survival following recurrence in ovarian cancer
2017 · Hiroaki Soyama, Masashi Takano, et al. · Molecular and Clinical Oncology · 14
PDF
A Pathological Study Using 2014 WHO Criteria Reveals Poor Prognosis of Grade 3 Ovarian Endometrioid Carcinomas
2018 · HIROAKI SOYAMA, MORIKAZU MIYAMOTO, et al. · In Vivo · 13
PDF
Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis
2018 · Kazuki Takasaki, Morikazu Miyamoto, et al. · Cancer Chemotherapy and Pharmacology · 11
Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis
2017 · Morikazu Miyamoto, Masashi Takano, et al. · Journal of Gynecologic Oncology · 11
Relation between Birth Weight and Intraoperative Hemorrhage during Cesarean Section in Pregnancy with Placenta Previa
2016 · Hiroaki Soyama, Morikazu Miyamoto, et al. · PLoS ONE · 11
PDF
Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review
2017 · Morikazu Miyamoto, Masashi Takano, et al. · Cancer Chemotherapy and Pharmacology · 10
Rapid decrease in serum VEGF-A levels may be a worse prognostic biomarker for patients with platinum-resistant recurrent ovarian cancer treated with bevacizumab and gemcitabine
2020 · Hiroaki Soyama, Morikazu Miyamoto, et al. · Cancer Chemotherapy and Pharmacology · 9
Role of endometriosis as a prognostic factor for post‑progression survival in ovarian clear cell carcinoma
2017 · Hiroki Ishibashi, Masashi Takano, et al. · Molecular and Clinical Oncology · 9
PDF
Low Expression of CD44 Is an Independent Factor of Poor Prognosis in Ovarian Mucinous Carcinoma
2018 · HIROKO MATUURA, MORIKAZU MIYAMOTO, et al. · Anticancer Research · 7
PDF
Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin
2017 · Hiroaki Soyama, Morikazu Miyamoto, et al. · Medical Oncology · 7
Pregnancy with asymptomatic uterine complete rupture after uterine artery embolization for postpartum hemorrhage
2017 · Hiroaki Soyama, Morikazu Miyamoto, et al. · Taiwanese Journal of Obstetrics and Gynecology · 7
PDF
Analysis about the influence on the fetus infected with parvovirus B19 using amniotic erythropoietin and troponin-T
2013 · Masashi Yoshida, Hideo Matsuda, et al. · Archives of Gynecology and Obstetrics · 7
Zone Formation of Lymphocyte Infiltration at Invasive Front as a Biomarker of Prognosis in Endometrial Carcinomas
2018 · Morikazu Miyamoto, Masashi Takano, et al. · Oncology · 6
Works count: 63
Citation count: 526
H-index: 13
I10-index: 18
Year
Topic
Type